Jefferies Maintains Buy Rating on Accuray Stock, Keeps PT at $4.5

Accuray Incorporated (NASDAQ:ARAY) is one of the 10 Best Small Cap Robotics Stocks to Buy Now. On June 9, Jefferies maintained a Buy rating on Accuray, with a price target of $4.5.

Young Li from Jefferies maintained a Buy rating on the stock, citing the company’s strategic initiatives and market positioning. Li remains positive about the way Accuray is handling tariff challenges and commends its strong foundation in the Chinese market. Li cited its recent exchange of convertible notes as a catalyst for its financial position. On June 6, the company entered into a new senior secured credit agreement, removing its “financial overhang” and improving its financial flexibility.

Jefferies Maintains Buy Rating on Accuray Stock, Keeps PT at $4.5

A researcher in a lab coat analyzing the effects of PD-L1 on GITR Expressing Cells to advance the targeted oncology.

After achieving a 12% year-over-year revenue growth in Q3 FY2025, Accuray expects revenue in the range of $121 million to $129 million. Whereas, the adjusted EBITDA is projected to be in the range of $9.5 million to $12 million. Both revenue and EBITDA guidance are well ahead of the results in Q3, indicating robust growth in both developed and emerging markets.

Accuray Incorporated (NASDAQ:ARAY) offers unique radiation treatments to meet patient needs. The company is focused on developing innovative solutions for oncology and neuro-radiosurgery.

While we acknowledge the potential of ARAY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ARAY and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.